Ertugliflozin, renoprotection and potential confounding by muscle wasting

Diabetologia. 2022 May;65(5):906-907. doi: 10.1007/s00125-021-05614-0. Epub 2021 Dec 23.

Authors

Dion Groothof¹, Adrian Post², Reinold O B Gans², Stephan J L Bakker²

Affiliations

¹ Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. d.groothof@umcg.nl.
² Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

PMID: 34940888
DOI: 10.1007/s00125-021-05614-0

No abstract available

Keywords: Confounding; Diabetic nephropathy; Ertugliflozin; Muscle mass; Renal function.

Publication types

Letter

MeSH terms

Bridged Bicyclo Compounds, Heterocyclic
Diabetes Mellitus, Type 2*
Humans
Muscles
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin